FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:304-309 July 29, 1993 Number 5 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background A cause-and-effect relation between blood glucose concentrations and microvascular complications in patients with insulin-dependent diabetes mellitus has not been established.

Methods We randomly assigned 102 patients with insulin-dependent diabetes mellitus, nonproliferative retinopathy, normal serum creatinine concentrations, and unsatisfactory blood glucose control to intensified insulin treatment (48 patients) or standard insulin treatment (54 patients). We then evaluated them for microvascular complications after 18 months and 3, 5, and 7.5 years.

Results Mean (±SD) glycosylated hemoglobin values were reduced from 9.5 ±1.3 percent to 7.1 ±0.7 percent in the group receiving intensified treatment and from 9.4 ±1.4 percent to 8.5 ±0.7 percent in the group receiving standard treatment (P = 0.001). In 12 of the patients receiving intensified treatment (27 percent of those included in the analysis) and 27 of those receiving standard treatment (52 percent), serious retinopathy requiring photocoagulation developed (P = 0.01). Visual acuity decreased in 6 patients receiving intensified treatment (14 percent) and in 18 receiving standard treatment (35 percent) (P = 0.02). Nephropathy (urinary albumin excretion, >200 µg per minute) developed in one patient in the group receiving intensified treatment, as compared with nine patients in the group receiving standard treatment (P = 0.01). No patient in the intensified-treatment group had nephropathy with subnormal glomerular filtration rates, as compared with six patients in the standard-treatment group (P = 0.02). The conduction velocities of the ulnar, tibial, peroneal, and sural nerves decreased significantly more in the standard-treatment group than in the intensified-treatment group. The odds ratio for serious retinopathy was 0.4 (95 percent confidence interval, 0.2 to 1.0; P = 0.04) in the intensified-treatment group as compared with the standard-treatment group. The corresponding odds ratio for nephropathy was 0.1 (95 percent confidence interval, 0 to 0.8; P = 0.04).

Conclusions Long-term intensified insulin treatment, as compared with standard treatment, retards the development of microvascular complications in patients with insulin-dependent diabetes mellitus.

Source Information

From the Departments of Internal Medicine (P.R.) and Clinical Neurophysiology (B.-Y.N.), Sodersjukhuset, and the Stockholm County Council Teaching Center for Diabetes and Karolinska Sjukhuset (U.R.), all in Stockholm, Sweden.

Address reprint requests to Dr. Reichard at the Department of Internal Medicine, Sodersjukhuset, 118 83 Stockholm, Sweden.

Full Text of this Article

This article has been cited by other articles:

• American Diabetes Association, (2010). Standards of Medical Care in Diabetes--2010. Diabetes Care 33: S11-S61 [Full Text]  
• Waden, J., Forsblom, C., Thorn, L. M., Gordin, D., Saraheimo, M., Groop, P.-H., on behalf of the Finnish Diabetic Nephropathy Stud, (2009). A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes. Diabetes 58: 2649-2655 [Abstract] [Full Text]  
• Diabetes Control and Complications Trial/Epidemiol, (2009). Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med 169: 1307-1316 [Abstract] [Full Text]  
• Brooks, A. M., Thacker, S. M (2009). Dapagliflozin for the Treatment of Type 2 Diabetes. The Annals of Pharmacotherapy 43: 1286-1293 [Abstract] [Full Text]  
• Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A.M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., Sherwin, R. S. (2009). Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 53: 298-304 [Full Text]  
• Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A.M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., Sherwin, R. S. (2009). Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 119: 351-357 [Full Text]  
• Jovanovic, D. B., Matanovic, D. D., Simic-Ogrizovic, S. P., Stosovic, M. D., Bontic, A. C., Nesic, V. D. (2009). POLYNEUROPATHY IN DIABETIC AND NONDIABETIC PATIENTS ON CAPD: IS THERE AN ASSOCIATION WITH HRQOL?. pdi 29: 102-107 [Abstract] [Full Text]  
• Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., Zinman, B. (2009). Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Clin. Diabetes 27: 4-16 [Full Text]  
• Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., Zinman, B. (2009). Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Spectr. 22: 6-17 [Full Text]  
• Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., Zinman, B. (2009). Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32: 193-203 [Abstract] [Full Text]  
• Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A.M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., Sherwin, R. S. (2009). Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association . Diabetes Care 32: 187-192 [Full Text]  
• Adams, H. P. Jr (2009). Secondary Prevention of Atherothrombotic Events After Ischemic Stroke. Mayo Clin Proc. 84: 43-51 [Abstract] [Full Text]  
• American Diabetes Association, (2009). Standards of Medical Care in Diabetes--2009. Diabetes Care 32: S13-S61 [Full Text]  
• Liu, I. M., Cheng, J. T. (2008). Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats. Evid Based Complement Alternat Med 0: nen078v1-nen078 [Abstract] [Full Text]  
• Finucane, M. L., McMullen, C. K. (2008). Making Diabetes Self-management Education Culturally Relevant for Filipino Americans in Hawaii. The Diabetes Educator 34: 841-853 [Abstract] [Full Text]  
• Bergenstal, R. M., Johnson, M., Powers, M. A., Wynne, A., Vlajnic, A., Hollander, P., Rendell, M. (2008). Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 31: 1305-1310 [Abstract] [Full Text]  
• Rossetti, P., Porcellati, F., Bolli, G. B., Fanelli, C. G. (2008). Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes: The role of insulin analogs. Diabetes Care 31: S113-S120 [Full Text]  
• Pearson, T. (2008). Glucagon as a Treatment of Severe Hypoglycemia: Safe and Efficacious but Underutilized. The Diabetes Educator 34: 128-134 [Abstract] [Full Text]  
• American Diabetes Association, (2008). Standards of Medical Care in Diabetes--2008. Diabetes Care 31: S12-S54 [Full Text]  
• Mohamed, Q., Gillies, M. C., Wong, T. Y. (2007). Management of Diabetic Retinopathy: A Systematic Review. JAMA 298: 902-916 [Abstract] [Full Text]  
• Wong, M.-c., Chung, J. W Y, Wong, T. K S (2007). Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 335: 87-87 [Abstract] [Full Text]  
• Testa, M. A., Simonson, D. C. (2007). Satisfaction and Quality of Life With Premeal Inhaled Versus Injected Insulin in Adolescents and Adults With Type 1 Diabetes. Diabetes Care 30: 1399-1405 [Abstract] [Full Text]  
• Nelson, S. C., Little, E. R. Jr. (2007). The 36-Item Short-Form Health Survey Outcome Evaluation for Multiple Lower-Extremity Nerve Decompressions in Diabetic Peripheral Neuropathy: A Pilot Study. J. Am. Podiatr. Med. Assoc. 97: 121-125 [Abstract] [Full Text]  
• Eeg-Olofsson, K., Cederholm, J., Nilsson, P. M., Gudbjornsdottir, S., Eliasson, B., for the Steering Committee of the Swedish National, (2007). Glycemic and Risk Factor Control in Type 1 Diabetes: Results from 13,612 patients in a national diabetes register. Diabetes Care 30: 496-502 [Abstract] [Full Text]  
• Brantsma, A. H., Atthobari, J., Bakker, S. J.L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., for the PREVEND Study Group, (2007). What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?. J. Am. Soc. Nephrol. 18: 637-645 [Abstract] [Full Text]  
• American Diabetes Association, (2007). Standards of Medical Care in Diabetes--2007. Diabetes Care 30: S4-S41 [Full Text]  
• Dworkin, L. D. (2006). Controversial Treatment of Atherosclerotic Renal Vascular Disease: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions Trial. Hypertension 48: 350-356 [Full Text]  
• Nathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., Zinman, B. (2006). Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29: 1963-1972 [Full Text]  
• Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T. (2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e409-e449 [Abstract] [Full Text]  
• Clozel, M., Hess, P., Qiu, C., Ding, S.-S., Rey, M. (2006). The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats. J. Pharmacol. Exp. Ther. 316: 1115-1121 [Abstract] [Full Text]  
• Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T. (2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 577-617 [Abstract] [Full Text]  
• American Diabetes Association, (2006). Standards of Medical Care in Diabetes-2006. Diabetes Care 29: S4-S42 [Full Text]  
• Rosenstock, J., Zinman, B., Murphy, L. J., Clement, S. C., Moore, P., Bowering, C. K., Hendler, R., Lan, S.-P., Cefalu, W. T. (2005). Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized, Controlled Trial. ANN INTERN MED 143: 549-558 [Abstract] [Full Text]  
• Carr, J. M., Sellke, F. W., Fey, M., Doyle, M. J., Krempin, J. A., de la Torre, R., Liddicoat, J. R. (2005). Implementing Tight Glucose Control After Coronary Artery Bypass Surgery. Ann. Thorac. Surg. 80: 902-909 [Abstract] [Full Text]  
• Skyler, J. S., Weinstock, R. S., Raskin, P., Yale, J.-F., Barrett, E., Gerich, J. E., Gerstein, H. C., the Inhaled Insulin Phase III Type 1 Diabetes Stud, (2005). Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial. Diabetes Care 28: 1630-1635 [Abstract] [Full Text]  
• Jorneskog, G., Kalani, M., Kuhl, J., Bavenholm, P., Katz, A., Allerstrand, G., Alvarsson, M., Efendic, S., Ostenson, C.-G., Pernow, J., Wahren, J., Brismar, K. (2005). Early Microvascular Dysfunction in Healthy Normal-Weight Males With Heredity for Type 2 Diabetes. Diabetes Care 28: 1495-1497 [Full Text]  
• Goldman-Levine, J. D, Lee, K. W (2005). Insulin Detemir--A New Basal Insulin Analog. The Annals of Pharmacotherapy 39: 502-507 [Abstract] [Full Text]  
• American Diabetes Association, (2005). Standards of Medical Care in Diabetes. Diabetes Care 28: S4-S36 [Full Text]  
• Hsieh, T.-J., Fustier, P., Wei, C.-C., Zhang, S.-L., Filep, J. G, Tang, S.-S., Ingelfinger, J. R, Fantus, I G., Hamet, P., Chan, J. S D (2004). Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol 183: 535-550 [Abstract] [Full Text]  
• Quattrin, T., Belanger, A., Bohannon, N. J.V., Schwartz, S. L., for the Exubera Phase III Study Group, (2004). Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes: Results of a 6-month, randomized, comparative trial. Diabetes Care 27: 2622-2627 [Abstract] [Full Text]  
• Skyler, J. S. (2004). Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Clin. Diabetes 22: 162-166 [Abstract] [Full Text]  
• Rosenstock, J., Cappelleri, J. C., Bolinder, B., Gerber, R. A. (2004). Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes. Diabetes Care 27: 1318-1323 [Abstract] [Full Text]  
• Boulton, A. J.M., Malik, R. A., Arezzo, J. C., Sosenko, J. M. (2004). Diabetic Somatic Neuropathies. Diabetes Care 27: 1458-1486 [Full Text]  
• Home, P., Bartley, P., Russell-Jones, D., Hanaire-Broutin, H., Heeg, J.-E., Abrams, P., Landin-Olsson, M., Hylleberg, B., Lang, H., Draeger, E. (2004). Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: A randomized clinical trial. Diabetes Care 27: 1081-1087 [Abstract] [Full Text]  
• Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., Kudva, Y. C. (2004). Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control: A randomized controlled trial and meta-analysis. Diabetes Care 27: 1088-1094 [Abstract] [Full Text]  
• Pogach, L. M., Brietzke, S. A., Cowan, C. L. Jr., Conlin, P., Walder, D. J., Sawin, C. T. (2004). Development of Evidence-Based Clinical Practice Guidelines for Diabetes: The Department of Veterans Affairs/Department of Defense Guidelines Initiative. Diabetes Care 27: B82-B89 [Abstract] [Full Text]  
• (2004). Standards of Medical Care in Diabetes. Diabetes Care 27: s15-35 [Full Text]  
• (2004). Prevention or Delay of Type 2 Diabetes. Diabetes Care 27: s47-47 [Full Text]  
• Svensson, M., Sundkvist, G., Arnqvist, H. J., Bjork, E., Blohme, G., Bolinder, J., Henricsson, M., Nystrom, L., Torffvit, O., Waernbaum, I., Ostman, J., Eriksson, J. W. (2003). Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26: 2903-2909 [Abstract] [Full Text]  
• Dallo, F. J., Weller, S. C. (2003). Effectiveness of diabetes mellitus screening recommendations. Proc. Natl. Acad. Sci. USA 100: 10574-10579 [Abstract] [Full Text]  
• Mulcahy, K., Maryniuk, M., Peeples, M., Peyrot, M., Tomky, D., Weaver, T., Yarborough, P. (2003). Diabetes Self-Management Education Core Outcomes Measures. The Diabetes Educator 29: 768-803  
• Larsen, J. R., Sjoholm, H., Hanssen, K. F., Sandvik, L., Berg, T. J., Dahl-Jorgensen, K. (2003). Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years' Duration of Type 1 Diabetes. Diabetes Care 26: 2400-2404 [Abstract] [Full Text]  
• Simpson, S. H., Corabian, P., Jacobs, P., Johnson, J. A. (2003). The cost of major comorbidity in people with diabetes mellitus. CMAJ 168: 1661-1667 [Abstract] [Full Text]  
• Buse, J. B. (2003). Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No!. Diabetes Care 26: 1615-1618 [Full Text]  
• Weissberg-Benchell, J., Antisdel-Lomaglio, J., Seshadri, R. (2003). Insulin Pump Therapy: A meta-analysis. Diabetes Care 26: 1079-1087 [Abstract] [Full Text]  
• Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W.F., Haahr, H., Kristensen, A., Draeger, E. (2003). Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart. Diabetes Care 26: 590-596 [Abstract] [Full Text]  
• Henricsson, M., Nystrom, L., Blohme, G., Ostman, J., Kullberg, C., Svensson, M., Scholin, A., Arnqvist, H. J., Bjork, E., Bolinder, J., Eriksson, J. W., Sundkvist, G. (2003). The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26: 349-354 [Abstract] [Full Text]  
• Ekberg, K., Brismar, T., Johansson, B.-L., Jonsson, B., Lindstrom, P., Wahren, J. (2003). Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes. Diabetes 52: 536-541 [Abstract] [Full Text]  
• Chen, J., Muntner, P., Hamm, L. L., Fonseca, V., Batuman, V., Whelton, P. K., He, J. (2003). Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults. J. Am. Soc. Nephrol. 14: 469-477 [Abstract] [Full Text]  
• Gerling, I. C., Solomon, S. S., Bryer-Ash, M. (2003). Genomes, Transcriptomes, and Proteomes: Molecular Medicine and Its Impact on Medical Practice. Arch Intern Med 163: 190-198 [Abstract] [Full Text]  
• Buse, J. B. (2003). Evolution in the American Diabetes Association Standards of Care. Clin. Diabetes 21: 24-26 [Full Text]  
• (2003). Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 26: s28-32 [Full Text]  
• (2003). Standards of Medical Care for Patients With Diabetes Mellitus. Diabetes Care 26: S33-S50 [Full Text]  
• (2003). The Prevention or Delay of Type 2 Diabetes. Diabetes Care 26: s62-69 [Full Text]  
• DiPetrillo, K., Coutermarsh, B., Gesek, F. A. (2003). Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am. J. Physiol. Renal Physiol. 284: F113-F121 [Abstract] [Full Text]  
• Poulsen, L. (2002). Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes. Journal of Renin-Angiotensin-Aldosterone System 3: 222-242 [Abstract]  
• Larsen, J., Brekke, M., Sandvik, L., Arnesen, H., Hanssen, K. F., Dahl-Jorgensen, K. (2002). Silent Coronary Atheromatosis in Type 1 Diabetic Patients and Its Relation to Long-Term Glycemic Control. Diabetes 51: 2637-2641 [Abstract] [Full Text]  
• (2002). The Prevention or Delay of Type 2 Diabetes. Clin. Diabetes 20: 109-116 [Full Text]  
• (2002). The Prevention or Delay of Type 2 Diabetes. Diabetes Spectr. 15: 147-157 [Full Text]  
• Nathan, D. M. (2002). The Impact of Clinical Trials on the Treatment of Diabetes Mellitus. J. Clin. Endocrinol. Metab. 87: 1929-1937 [Abstract] [Full Text]  
• Sidorov, J., Shull, R., Tomcavage, J., Girolami, S., Lawton, N., Harris, R. (2002). Does Diabetes Disease Management Save Money and Improve Outcomes? : A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria . Diabetes Care 25: 684-689 [Abstract] [Full Text]  
• American Diabetes Association, (2002). The Prevention or Delay of Type 2 Diabetes. Diabetes Care 25: 742-749 [Full Text]  
• Henricsson, M., Berntorp, K., Fernlund, P., Sundkvist, G. (2002). Progression of Retinopathy in Insulin-Treated Type 2 Diabetic Patients. Diabetes Care 25: 381-385 [Abstract] [Full Text]  
• (2002). Standards of Medical Care for Patients With Diabetes Mellitus. Diabetes Care 25: 213-229 [Full Text]  
• Scott, L. J., Warram, J. H., Hanna, L. S., Laffel, L. M. B., Ryan, L., Krolewski, A. S. (2001). A Nonlinear Effect of Hyperglycemia and Current Cigarette Smoking Are Major Determinants of the Onset of Microalbuminuria in Type 1 Diabetes. Diabetes 50: 2842-2849 [Abstract] [Full Text]  
• Fihn, S. D., Williams, S. V., Daley, J., Gibbons, R. J. (2001). Guidelines for the Management of Patients with Chronic Stable Angina: Treatment. ANN INTERN MED 135: 616-632 [Abstract] [Full Text]  
• Fleming, B. B., Greenfield, S., Engelgau, M. M., Pogach, L. M., Clauser, S. B., Parrott, M. A. (2001). The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24: 1815-1820 [Full Text]  
• Gerber, R. A., Cappelleri, J. C., Kourides, I. A., Gelfand, R. A. (2001). Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 Diabetes: A randomized controlled trial. Diabetes Care 24: 1556-1559 [Abstract] [Full Text]  
• Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., El-Kebbi, I. M. (2001). Hypoglycemia in Patients With Type 2 Diabetes Mellitus. Arch Intern Med 161: 1653-1659 [Abstract] [Full Text]  
• Rose, S. R. (2001). Nasal Insulin and Diabetes Control. AAP Grand Rounds 6: 5-6 [Full Text]  
• American Diabetes Association, (2001). Postprandial Blood Glucose. Clin. Diabetes 19: 127-130 [Full Text]  
• Krishnamurti, U., Steffes, M. W. (2001). Glycohemoglobin: A Primary Predictor of the Development or Reversal of Complications of Diabetes Mellitus. Clin. Chem. 47: 1157-1165 [Abstract] [Full Text]  
• Skeie, S., Thue, G., Sandberg, S. (2001). Interpretation of Hemoglobin A1c (HbA1c) Values among Diabetic Patients: Implications for Quality Specifications for HbA1c. Clin. Chem. 47: 1212-1217 [Abstract] [Full Text]  
• Leiter, L. A., Barr, A., Bélanger, A., Lubin, S., Ross, S. A., Tildesley, H. D., Fontaine, N. (2001). Diabetes Screening in Canada (DIASCAN) Study: Prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 24: 1038-1043 [Abstract] [Full Text]  
• American Diabetes Association, (2001). Postprandial Blood Glucose. Diabetes Care 24: 775-778 [Full Text]  
• American Diabetes Association, (2001). How Do We Diagnose Diabetes and Measure Blood Glucose Control?: View 2: (Measuring Control) Consensus Statement: Postprandial Blood Glucose. Diabetes Spectr. 14: 71-74 [Full Text]  
• HADJADJ, S., BELLOUM, R., BOUHANICK, B., GALLOIS, Y., GUILLOTEAU, G., CHATELLIER, G., ALHENC-GELAS, F., MARRE, M. (2001). Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus: A Prospective Study. J. Am. Soc. Nephrol. 12: 541-549 [Abstract] [Full Text]  
• Perkins, B. A., Olaleye, D., Zinman, B., Bril, V. (2001). Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic. Diabetes Care 24: 250-256 [Abstract] [Full Text]  
• Hermansen, K., Madsbad, S., Perrild, H., Kristensen, A., Axelsen, M. (2001). Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin: A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 24: 296-301 [Abstract] [Full Text]  
• Davidson, M. B., Karlan, V. J., Hair, T. L. (2000). Effect of a Pharmacist-Managed Diabetes Care Program in a Free Medical Clinic. American Journal of Medical Quality 15: 137-142 [Abstract]  
• Benson, K., Hartz, A. J. (2000). A Comparison of Observational Studies and Randomized, Controlled Trials. NEJM 342: 1878-1886 [Abstract] [Full Text]  
• Bergh, A.-L., Persson, L.-O., Attvall, S. (2000). Psychometric properties of the Swedish version of the Well-Being Questionnaire in a sample of patients with diabetes type 1. Scand J Public Health 28: 137-145 [Abstract]  
• Plum, A., Agersø, H., Andersen, L. (2000). Pharmacokinetics of the Rapid-Acting Insulin Analog, Insulin Aspart, in Rats, Dogs, and Pigs, and Pharmacodynamics of Insulin Aspart in Pigs. Drug Metab. Dispos. 28: 155-160 [Abstract] [Full Text]  
• Poulsen, P. L., Hansen, K. W., Ebbehøj, E., Knudsen, S. T., Mogensen, C. E. (2000). No Deleterious Effects of Tight Blood Glucose Control on 24-Hour Ambulatory Blood Pressure in Normoalbuminuric Insulin-Dependent Diabetes Mellitus Patients. J. Clin. Endocrinol. Metab. 85: 155-158 [Abstract] [Full Text]  
• Zhang, S.-L., Chen, X., Filep, J. G., Tang, S.-S., Ingelfinger, J. R., Chan, J. S. D. (1999). Insulin Inhibits Angiotensinogen Gene Expression via the Mitogen-Activated Protein Kinase Pathway in Rat Kidney Proximal Tubular Cells. Endocrinology 140: 5285-5292 [Abstract] [Full Text]  
• Landstedt-Hallin, L., Adamson, U., Lins, P.-E. (1999). Oral Glibenclamide Suppresses Glucagon Secretion during Insulin-Induced Hypoglycemia in Patients with Type 2 Diabetes. J. Clin. Endocrinol. Metab. 84: 3140-3145 [Abstract] [Full Text]